Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer.
Stein SM, James ES, Deng Y, Cong X, Kortmansky JS, Li J, Staugaard C, Indukala D, Boustani AM, Patel V, Cha CH, Salem RR, Chang B, Hochster HS, Lacy J.
Stein SM, et al. Among authors: cong x.
Br J Cancer. 2016 Mar 29;114(7):737-43. doi: 10.1038/bjc.2016.45.
Br J Cancer. 2016.
PMID: 27022826
Free PMC article.
Clinical Trial.